Middle East and Africa Blood Culture Tests Market Research Report – Segmented By Method, Product, Technology, Application, End User & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) – Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Updated On: June, 2024
ID: 7555
Pages: 145

MEA Blood Culture Tests Market Size (2023 to 2028)

The size of the Middle East and Africa Blood Culture Tests market is anticipated to grow at 8.25% CAGR between 2023 to 2028. The Middle East and Africa market was estimated to be valued at USD 10.27 billion in 2023 and is expected to reach USD 15.26 billion by 2028.

The market for MEA blood culture tests is expanding due to an older population, increased sepsis incidences, and developments in medical technology. In addition, raising awareness of sepsis and a high prevalence of bloodstream infections (BSI) among governments and the general public has increased government activities. Furthermore, a rise in demand for quick diagnostic procedures and a high frequency of infectious illnesses are a few other drivers propelling the market forward.

In addition, factors such as an increasing number of sepsis cases, government awareness, a high percentage of aging populations across countries, rapid improvements in medical technology, improving patient identification, and increasing adoption rates of emerging innovations are expected to boost the market expansion of blood culture tests in the Middle East and Africa.

However, strict government rules are estimated to be limiting the market's expansion to some extent. Because of the strictness of the tests, the kits and instruments must go through extensive testing before being approved, which increases their cost and makes the entire operation more expensive. Long trials also resulted in product introductions being delayed, which has a negative influence on trials. When long clinical studies are costly, and the final operation is postponed. All of these problems are impeding the market's expansion.

This research report on the Middle East and Africa blood culture tests market has been segmented & sub-segmented into the following categories:

By Product:

  • Consumables
    • Blood Culture Media    
      • Aerobic Blood Culture Media
      • Pediatric Aerobic Blood Culture Media
      • Anaerobic Blood Culture Media
      • Mycobacterial Blood Culture Media
      • Fungi Blood Culture Media
    • Assay Kits & Reagents   
    • Blood Culture Accessories
  • Instruments
    • Automated Blood Culture Systems      
    • Supporting Laboratory Equipment       
      • Incubators
      • Colony Counters
      • Microscopes
      • Gram Stainers
  • Software and Services

By Technology:

  • Culture-Based Technology
  • Molecular Technologies
    • Microarrays
    • PCR (Polymerase Chain Reaction)       
    • PNA-FiSH (Peptide Nucleic Acid – Fluorescent in Situ Hybridization)       
  • Proteomics Technology     

By Application:

  • Bacteremia
  • Fungemia
  • Mycobacterial Detection

By End User:

  • Hospital Laboratories
  • Reference Laboratories

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Middle East is expected to have the highest growth rate of the MEA Blood testing and screening market in the forecast period, whereas Africa is already a leading market. Within the limited funding available, the government promotes healthcare and facilities in this region to capitalize on the market boom. For instance, the government encourages home treatment to provide excellent hospitality and health, reduce hospital stays, and reduce expenses. This increased the market size of portable blood testing kits considerably.

The costs of disease-related hospitality and health care in Soviet Central Asia are monitored by various government and non-government organizations. Due to their growth and modernization, it is easier and more convenient to find clinics, diagnostic centers, physician's offices, and blood testing markets. South Africa and Nigeria have high rates of blood donation camps and cancer diagnostics, in addition to blood banking units. Additionally, in the Middle East and Africa, there is a shift in focus towards point-of-care diagnostics. Diagnostic blood tests are sugar tests, lipid tests, glucose tests, electrolytes, and coagulation tests.


The market is dominated by companies like Becton, Dickinson and Company, bioMérieux SA, Thermo Fisher Scientific Inc., Cepheid, Inc., Nanosphere Inc., IRIDICA, Beckman Coulter, Bruker Corporation, and T2 Biosystems.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1200

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample